Specialty medications often have dispensing restrictions which can be dictated by manufacturer limited distribution strategies, narrow insurance networks, or a combination of both. Unfortunately, this may result in patients being required to use 2 or more pharmacies to fill their prescription medications; this is referred to as multiple pharmacy use (MPU). The investigators' plan is to administer a survey to patients who have been prescribed one or more specialty medications to evaluate the prevalence of MPU in this population as well as to investigate patients' attitudes about MPU and potential factors increasing the likelihood of MPU

The investigators will identify patients from participating member sites via a review of prescribing records for specific specialty medications. Patients will be contacted via telephone to explain the purpose and risk of the study. Consented patients will then be asked a series of 11 questions about their attitudes and experience with taking and obtaining their specialty medication(s). Additional demographic and clinical information about patients will be collected via chart review.

Inclusion Criteria:

• Subjects 18 years of age or older
• English-speakers
• An active patient of a performance institution and ability to provide informed consent to participate with the survey
• Electronically prescribed at least one specialty medication by a performance site provider, which can be either a new or renewed order, within the last 3 months

Exclusion Criteria:

• Subjects less than 18 years of age
• Non-English speakers
• Patients that cannot or are unwilling to provide consent
• Patients who have not had a new or renewed specialty medication prescription order placed electronically within the last 3 months

De-identified data from individual study sites will be collected and stored together either via a password-protected Excel file or Qualtrics.